Clarivate (CLVT) Stock Analysis & Winston Score

Clarivate is a data and analytics company that helps scientists, researchers, lawyers, and businesses find and use specialized information. Its main products include Web of Science (a database of academic research), Derwent (patent data), and Cortellis (life sciences intelligence). It serves universities, pharmaceutical companies, law firms, and corporations that need reliable data to make decisions about research, patents, and intellectual property. Clarivate makes most of its money through subscriptions, where customers pay annually to access its databases and software tools. It operates globally, with significant revenue from North America, Europe, and Asia, and generates roughly $2.5 billion in annual revenue. Its moat comes from the depth and history of its proprietary datasets, which are difficult and expensive to replicate. However, the company carries a heavy debt load from past acquisitions, and its low ROIC of 1.3% signals that it has struggled to turn that scale into strong returns — managing that debt while growing revenue remains its central challenge.